Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.
about
Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic interventionCumulative exposure to lead in relation to cognitive function in older womenTherapies targeting lipid peroxidation in traumatic brain injuryEffect of metals on kinetic pathways of amyloid-β aggregationOxidative stress in the progression of Alzheimer disease in the frontal cortex.Alzheimer's disease and neuronal network activityPreclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.Serum lycopene, lutein and zeaxanthin, and the risk of Alzheimer's disease mortality in older adults.Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brainAccumulation of nuclear DNA damage or neuron loss: molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases.RNA oxidation catalyzed by cytochrome c leads to its depurination and cross-linking, which may facilitate cytochrome c release from mitochondria.DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes.Neurobiology of the aging dog.Serum uric acid and subsequent cognitive performance in patients with pre-existing cardiovascular diseaseProtective effects of vitamin E against hypercholesterolemia-induced age-related diseasesA neurovascular perspective for long-term changes after brain trauma.Physiological antioxidative network of the bilirubin system in aging and age-related diseases.Candidate genes for Alzheimer's disease are associated with individual differences in plasma levels of beta amyloid peptides in adults with Down syndrome.Does ionizing radiation influence Alzheimer's disease risk?New perspectives on central and peripheral immune responses to acute traumatic brain injury.Ascorbic acid, cognitive function, and Alzheimer's disease: a current review and future direction.Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models.Oxidative Stress Levels in Aqueous Humor from High Myopic Patients.MicroRNAs (miRNAs) in neurodegenerative diseases.Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease.Antioxidants in central nervous system diseases: preclinical promise and translational challenges.Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease.Therapeutics for Alzheimer's disease based on the metal hypothesisMultifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.The neuropathological profile of mild cognitive impairment (MCI): a systematic review.Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients.Cognitive and neuroprotective effects of chlorogenic acid.Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases.The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases.Inhibitory effect of some tropical green leafy vegetables on key enzymes linked to Alzheimer's disease and some pro-oxidant induced lipid peroxidation in rats' brain.Status of neurocognitive and oxidative stress conditions in iron-steel workers.MicroRNAs as newer therapeutic targets: A big hope from a tiny player.Ablation of the locus coeruleus increases oxidative stress in tg-2576 transgenic but not wild-type mice.Preconditioning with Gua Lou Gui Zhi decoction enhances H2O2-induced Nrf2/HO-1 activation in PC12 cells.Organoselenium (Sel-Plex diet) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 mice.
P2860
Q26865358-A7D0D6E6-B4FA-4223-B430-C6D938715CF8Q28388605-A661D208-F429-44AC-A01D-F4B6BDE75A56Q28394424-F43C867D-9164-4F09-83A9-E7B967237843Q33649803-2087FC2A-AEE4-4A59-8657-4D6AAA52097CQ33680790-A1FD6423-8951-4557-890D-CE57CE7DA659Q33708039-3E59681D-40B5-4A43-9F28-9CFB349C36F4Q33912803-D8ECEE5A-0E49-4551-A5F8-C6D5F7E8508FQ34038957-3F959713-F691-439B-A8B9-B12DDBA83DCBQ34268519-3FF44885-236B-43C4-BE8D-BFE8302AF162Q34775987-9072A9D7-A561-4905-95E4-4A49BE761A27Q35056112-AD502EC0-D1F5-42E7-A58E-F78D29F1C842Q35098038-BF28E5EA-FA80-48E3-8F14-3D211F89E02AQ35201102-0E11D7C0-68D4-442B-886C-624EBC8E525DQ35202983-6297342A-8236-453A-912D-3F0AF8362521Q35648904-B0A1E7DA-3226-48F8-A215-50EFEB00612EQ35763336-A7280FEE-DEB9-4BA8-A239-1E014BF7769CQ35828459-7814765F-0A4E-46FF-B6F1-B76CBB89219AQ36037548-388FD386-6854-4439-8917-4D25B4AE7FDBQ36355750-97A24F1A-A2E6-4E53-A3DD-E8DBEAB438CCQ36478408-D6B182A9-B320-40D0-9F93-EA929692373DQ36675775-B2043DB9-A55B-43C7-9749-114CAFEA359EQ36761675-7C20F9D6-DD78-4BA4-A1EA-880B4581DDF7Q36932305-652F1099-10A0-455B-9927-3DD531F5D8A7Q37069478-ED718155-B371-4B27-814C-7732174342B6Q37075304-0742B40F-2670-44F1-A3CA-9E07DEDA3AABQ37159979-A4A8BCFE-0E7C-4616-B4C6-E0F89F2D86A7Q37174350-FC3E18E0-2250-4B72-8B9D-A493786B605FQ37215856-F224C51E-C591-4DFB-8878-B35B24AA6997Q37603401-A4B573F4-7E6F-4783-AE6A-06211742D567Q37964897-1B8EFC25-8991-463F-964D-5C88393D3A91Q38109094-730BFBA4-0A5F-4675-9707-E37601BE866AQ38240601-F372C251-C33A-4F59-AB57-FE2C9D71E3B5Q38424367-F291FC18-7A51-40C6-AC0C-AC6464194076Q38692816-D5540A81-4FF6-4AA9-B4CC-561392D56061Q39181669-A38D8EB0-5C3F-4196-BE0E-6A3C3275B9FFQ39440794-8179DD79-A0CE-4514-AFCF-7C3DF51D5B32Q41547602-CBDA8F5C-3539-474D-8F1E-B2F61A59871AQ41988079-5C62AFE6-54C7-4DAD-A89E-D3B0EE03836BQ42057365-AA05482D-3D19-44F8-A967-8FAF5121EA4BQ43125551-0005931C-0A21-4720-92D9-AAF57CC71AFB
P2860
Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.
@en
type
label
Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.
@en
prefLabel
Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.
@en
P1433
P1476
Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.
@en
P2093
Mark A Lovell
William R Markesbery
P304
P356
10.1001/ARCHNEUR.64.7.954
P577
2007-07-01T00:00:00Z